Healthcare Professionals
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
MRI Overview
How many of your patients are excluded from the benefits of MRI because of their implantable cardiac device?
Most likely several since cardiac devices have not been considered safe in the MRI environment.
As MRI use increases, so too does the number of patients benefiting from pacemakers and implantable cardioverter defibrillators (ICDs). This convergence results in an escalating number of patients who may be denied MR diagnostic imaging.
Convergence of Trends:
Many Patients Potentially Denied MR Scans
Detail - Pacemaker and ICD Implants - Prevalence of Implantable Pulse Generators (IPGs) and Implantable Cardioverter Defibrillators (ICDs) implanted in the U.S. 1993-2004.*
Detail - MRI Procedures - Total US MRI procedure volume, hospital and non-hospital sites, 1993-2003.†
Recently, the FDA approved the Revo MRI SureScan Pacing System designed for use in the MRI environment under specified conditions.
The Revo MRI SureScan pacing system is MR Conditional designed to allow patients to undergo MRI under the specified conditions for use. A complete system, consisting of a Medtronic Revo MRI SureScan IPG implanted with two CapSureFix MRI™ SureScan leads is required for use in the MRI environment.
Medtronic Viewpoint
Medtronic does not support the off-label use of its products and believes that the safe use of implantable cardiac devices in the MR environment cannot be guaranteed unless devices are designed to be safe from the ground up. And such devices must be backed by rigorous scientific testing as well as review from appropriate regulatory agencies.
Medtronic recognizes that under certain circumstances, physicians will determine that the medical benefit of conducting an MRI on a patient with an implanted cardiac device outweighs the associated risks. But Medtronic cautions the scientific community about drawing conclusions from limited studies that have reported no adverse events. MRI experts Kanal and Gimbel clearly state: …failing to identify an adverse event is not equivalent to demonstrating safety1… in small studies with products not intended for the MR environment.
This is especially true since the hazards associated with scanning devices have a low frequency of occurrence. Furthermore, research needs to account for numerous variables, including inconsistency among MRI manufacturers, lead type and length, anatomical position of implant, and scan parameters. All these variables can change with the introduction of new cardiac devices and leads, and the continuous evolution of MRI technology.
The Revo MRI™ SureScan® Pacing System is the first MR-conditional FDA approved pacing system.
The Revo MRI SureScan pacing system is MR Conditional designed to allow patients to undergo MRI under the specified conditions for use. A complete system, consisting of a Medtronic Revo SureScan IPG implanted with two CapSureFid MRI™ SureScan leads is required for use in the MRI environment.
Medtronic has an ongoing commitment to design future device systems to be safe in MRI scanners. Physicians and their patients should accept nothing less than this commitment to safety and quality.
For other industry and government viewpoints, refer to the April 2005 issue of PACE.
Gimbel J and Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol. 2004;43:1325-1327.
MRI has different sources of electromagnetic interference:
Electromagnetic interference (EMI) produced during the MRI has the potential to induce several hazardous effects on implantable cardiac devices:
Effects of Static Magnetic Field
Effects of Gradient Magnetic Fields
The gradient (changing) magnetic fields may induce voltages/currents on the implanted lead(s) causing the following hazards:
Effects of Radio Frequency Waves
The RF waves may induce energy on implanted leads causing the following hazards:
Effects of Combined EM Fields (Static Magnetic, Gradient Magnetic, and/or RF)
Clinical Controversy
Despite theoretical and actual risks of MR scanning to patients with cardiac devices, the safety debate continues.
“...failing to identify an adverse event is not equivalent to demonstrating safety-especially when only a limited number of patients are studied...”1
J. Rod Gimbel, MD, FACC
Emanuel Kanal, MD, FACR
Gimbel J and Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol. 2004;43:1325-1327.
Copyrighted information provided with permission from IMV Medical Information Division. 2004 MRI Benchmark Report.
Cumulative implants minus mortality. Medtronic data on file.
Modern implantable heart devices safe for use in the MRI scans. Cardiovascular Week. 2005; March 28:193.
Medtronic data on file.
Magnetic Resonance Imaging Equipment-Global Strategy Business Report, Global Industry Analysts, Inc. San Jose, CA. 2002.
2002/03 MRI Benchmark Report, IMV Medical Information Division. Des Plaines, IL. 2003.
GE Medical Systems. Waukesha, WI. Press Release, 2002.